Pyrazolopyrimidinol, identified by the CAS number 12771-69-6, is a heterocyclic organic compound that features a fused pyrazole and pyrimidine ring system. This compound is characterized by its unique structural framework, which contributes to its potential biological activity. Pyrazolopyrimidinol derivatives are often investigated for their pharmacological properties, including anti-inflammatory, analgesic, and antitumor activities. The presence of hydroxyl groups in the structure enhances its solubility and reactivity, making it a versatile compound in medicinal chemistry. Additionally, the electronic properties of the fused rings can influence the compound's interaction with biological targets, leading to varied therapeutic applications. Pyrazolopyrimidinol is typically synthesized through multi-step organic reactions, and its derivatives can be tailored for specific biological activities. As with many heterocycles, the study of pyrazolopyrimidinol and its derivatives continues to be an area of interest in drug discovery and development.

Pyrazolopyrimidinol

12771-69-6: Pyrazolopyrimidinol, identified by the CAS number 12771-69-6, is a heterocyclic organic compound that features a fused pyrazole and pyrimidine ring system. This compound is characterized by its unique structural framework, which contributes to its potential biological activity. Pyrazolopyrimidinol derivatives are often investigated for their pharmacological properties, including anti-inflammatory, analgesic, and antitumor activities. The presence of hydroxyl groups in the structure enhances its solubility and reactivity, making it a versatile compound in medicinal chemistry. Additionally, the electronic properties of the fused rings can influence the compound's interaction with biological targets, leading to varied therapeutic applications. Pyrazolopyrimidinol is typically synthesized through multi-step organic reactions, and its derivatives can be tailored for specific biological activities. As with many heterocycles, the study of pyrazolopyrimidinol and its derivatives continues to be an area of interest in drug discovery and development.

CAS 12771-69-6

Pyrazolopyrimidinol

Pyrazolopyrimidinol (9CI)

Ref: IN-DA000XCL